InMode (INMD) Competitors $16.79 +0.22 (+1.33%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipShort InterestTrends INMD vs. INSP, NARI, PRCT, NVST, IRTC, NVCR, LIVN, ENOV, WRBY, and TNDMShould you be buying InMode stock or one of its competitors? The main competitors of InMode include Inspire Medical Systems (INSP), Inari Medical (NARI), PROCEPT BioRobotics (PRCT), Envista (NVST), iRhythm Technologies (IRTC), NovoCure (NVCR), LivaNova (LIVN), Enovis (ENOV), Warby Parker (WRBY), and Tandem Diabetes Care (TNDM). These companies are all part of the "medical equipment" industry. InMode vs. Inspire Medical Systems Inari Medical PROCEPT BioRobotics Envista iRhythm Technologies NovoCure LivaNova Enovis Warby Parker Tandem Diabetes Care Inspire Medical Systems (NYSE:INSP) and InMode (NASDAQ:INMD) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, media sentiment, community ranking, valuation, earnings, analyst recommendations, institutional ownership and profitability. Does the MarketBeat Community believe in INSP or INMD? Inspire Medical Systems received 26 more outperform votes than InMode when rated by MarketBeat users. However, 73.85% of users gave InMode an outperform vote while only 61.31% of users gave Inspire Medical Systems an outperform vote. CompanyUnderperformOutperformInspire Medical SystemsOutperform Votes18761.31% Underperform Votes11838.69% InModeOutperform Votes16173.85% Underperform Votes5726.15% Do analysts rate INSP or INMD? Inspire Medical Systems currently has a consensus target price of $232.55, suggesting a potential upside of 30.67%. InMode has a consensus target price of $22.40, suggesting a potential upside of 33.41%. Given InMode's higher possible upside, analysts plainly believe InMode is more favorable than Inspire Medical Systems.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Inspire Medical Systems 0 Sell rating(s) 3 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.73InMode 0 Sell rating(s) 4 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33 Which has stronger earnings & valuation, INSP or INMD? InMode has lower revenue, but higher earnings than Inspire Medical Systems. InMode is trading at a lower price-to-earnings ratio than Inspire Medical Systems, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInspire Medical Systems$624.80M8.54-$21.15M$1.07166.33InMode$492.05M2.87$197.92M$1.859.08 Is INSP or INMD more profitable? InMode has a net margin of 36.26% compared to Inspire Medical Systems' net margin of 4.37%. InMode's return on equity of 21.46% beat Inspire Medical Systems' return on equity.Company Net Margins Return on Equity Return on Assets Inspire Medical Systems4.37% 5.30% 4.58% InMode 36.26%21.46%19.19% Which has more volatility & risk, INSP or INMD? Inspire Medical Systems has a beta of 1.32, meaning that its share price is 32% more volatile than the S&P 500. Comparatively, InMode has a beta of 2.12, meaning that its share price is 112% more volatile than the S&P 500. Do institutionals & insiders have more ownership in INSP or INMD? 94.9% of Inspire Medical Systems shares are owned by institutional investors. Comparatively, 68.0% of InMode shares are owned by institutional investors. 4.1% of Inspire Medical Systems shares are owned by company insiders. Comparatively, 6.9% of InMode shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Does the media prefer INSP or INMD? In the previous week, Inspire Medical Systems had 8 more articles in the media than InMode. MarketBeat recorded 11 mentions for Inspire Medical Systems and 3 mentions for InMode. Inspire Medical Systems' average media sentiment score of 0.78 beat InMode's score of 0.21 indicating that Inspire Medical Systems is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Inspire Medical Systems 7 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive InMode 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryInspire Medical Systems and InMode tied by winning 9 of the 18 factors compared between the two stocks. Get InMode News Delivered to You Automatically Sign up to receive the latest news and ratings for INMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart INMD vs. The Competition Export to ExcelMetricInModeElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.41B$3.52B$5.21B$9.14BDividend YieldN/A1.73%5.13%4.02%P/E Ratio9.0818.0889.3417.36Price / Sales2.8769.461,240.0477.11Price / Cash7.1941.1043.7535.97Price / BookN/A3.915.314.79Net Income$197.92M$94.49M$122.54M$225.00M7 Day Performance5.13%4.58%0.59%2.62%1 Month Performance-1.70%4.10%2.55%3.81%1 Year Performance-25.68%4.21%25.29%20.10% InMode Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)INMDInMode3.0197 of 5 stars$16.79+1.3%$22.40+33.4%-25.7%$1.41B$492.05M9.08480INSPInspire Medical Systems4.8651 of 5 stars$177.97+2.4%$232.55+30.7%-11.4%$5.33B$624.80M166.331,011NARIInari Medical1.6924 of 5 stars$79.55+0.2%$68.00-14.5%+38.4%$4.66B$493.63M-58.931,300PRCTPROCEPT BioRobotics2.9036 of 5 stars$76.02-3.6%$97.86+28.7%+66.9%$3.97B$136.19M-38.98430Positive NewsGap DownHigh Trading VolumeNVSTEnvista3.4717 of 5 stars$19.83+3.3%$20.21+1.9%-16.3%$3.41B$2.57B-2.5512,800IRTCiRhythm Technologies1.3312 of 5 stars$108.33+1.3%$108.45+0.1%-1.1%$3.39B$492.68M-22.292,000NVCRNovoCure3.3166 of 5 stars$26.17+0.6%$32.67+24.8%+87.2%$2.83B$509.34M-18.691,453Analyst RevisionLIVNLivaNova3.3774 of 5 stars$48.30+0.7%$69.17+43.2%-3.9%$2.62B$1.15B115.002,900ENOVEnovis3.302 of 5 stars$46.68+2.7%$67.00+43.5%-22.0%$2.61B$1.71B-21.326,550Short Interest ↑News CoverageWRBYWarby Parker2.3634 of 5 stars$24.57-6.3%$20.92-14.9%+86.4%$2.50B$669.77M-90.983,491Analyst ForecastTNDMTandem Diabetes Care4.5216 of 5 stars$35.15-6.3%$53.81+53.1%+42.0%$2.31B$747.72M-18.212,400Positive News Related Companies and Tools Related Companies INSP Alternatives NARI Alternatives PRCT Alternatives NVST Alternatives IRTC Alternatives NVCR Alternatives LIVN Alternatives ENOV Alternatives WRBY Alternatives TNDM Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:INMD) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump secret stock already up 339% In this video, you’ll also get nine other Trump-connected investments… All of which we believe could have a...Porter & Company | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredStunning Trump Exec Order LeakedMost people have no clue this unassuming facility exists. Yet the minute Donald Trump takes office... ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InMode Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share InMode With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.